American Conference Institutes Life Sciences Collaborative Agreements and Acquisitions

May 16, 2011 - PRLog -- The flurry of big-dollar deals and the upswing in mergers and acquisitions in 2011 points to a clear trend: successful collaborative agreements are integral to a company’s ability to bring products to the market and to develop the next generation of therapeutic blockbusters in light of the impending patent cliff. At ACI’s Fifteenth Advanced Forum on Structuring, Negotiating, and Managing Life Sciences Collaborative Agreements and Acquisitions, learn proven effective techniques to structure alliances and negotiate the best terms to meet your company’s critical needs.

Meet the key dealmakers who will give you the contacts and intelligence you need to launch your company and product portfolio to the next level

A frontline faculty of senior industry insiders- including senior executives and corporate counsel from Merck, Amgen, Genentech, Gilead, Pfizer, Medtronic, GlaxoSmithKline and many more- will share best practices to enable your company to advance its key business development strategies, including:

·         Expand product lines through new technology and entrance into strategic emerging markets

·         Structuring options and payments to meet specific financial needs and account for cost and risk sharing

·         Negotiating partnerships and obtaining funding to translate early stage research into commercial products

·         Positioning your IP portfolio to increase market power

·         Building flexible provisions for potential future M&A into your agreement

Replenish pipelines, reduce development costs and risks, and leverage existing assets

While there are many challenges for life science companies in the current economy, including the looming loss of patent protection on many blockbuster drugs and skyrocketing research and development costs, there is also an enormous potential for growth through strategic partnerships.  This conference will arm you with the tools and connections to maximize the value of any deal and protect your assets.

Be confident that there are no impediments to commercializing the IP that is being gained

Protect potentially lucrative business opportunities and spot the red flags that can cause a good deal to go bad at our full-day post-conference Master Class: Life Sciences IP Due Diligence Boot Camp.  Whether you are on the acquiring side or the targeted side, you cannot afford to miss the opportunity to learn proven-effective tactics from leading in-house IP counsel to determine the value of the true commercial value of the property.

Read more about this at: http://americanconference.com/2011/754/life-sciences-coll...

# # #

A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.